ASCL1 DNA-Binding Mode: E-Protein Heterodimer vs. Homodimer — Final Report

Executive Judgment

Verdict: Supported — ASCL1 is a functionally obligate E-protein heterodimer; the GO:0042802 (identical protein binding) IEA annotation is over-annotated and should be replaced.

The seed hypothesis that human ASCL1 (P50553) binds DNA functionally as a heterodimer with class I E-proteins — not as a homodimer — is strongly supported by convergent structural, biochemical, evolutionary, and regulatory evidence spanning six independent lines of investigation. The current GO:0042802 annotation derives solely from automated Ensembl Compara ortholog transfer (GO_REF:0000107) and lacks any direct experimental basis. In contrast, experimentally validated annotations (IPI, IDA) consistently support heterodimer-mediated E-box binding. The most important caveat is that ASCL1 homodimers can form in vitro under artificial conditions (PMID: 19389376), but these require additional undefined factors for DNA binding and have never been demonstrated to function in vivo. The qualifier "functionally obligate" heterodimer accurately captures this nuance.

Summary

Human ASCL1 is a class II basic helix-loop-helix (bHLH) transcription factor that plays essential roles in neurogenesis, neuroendocrine differentiation, and cellular reprogramming. A Gene Ontology annotation (GO:0042802, "identical protein binding") inferred electronically suggests ASCL1 functions as a homodimer, but our systematic investigation of primary literature, structural data, evolutionary comparisons, and regulatory logic demonstrates that ASCL1's functional DNA-binding mode is heterodimerization with class I E-proteins such as TCF3/E2A (products E12 and E47), TCF4/E2-2, and TCF12/HEB.

This conclusion rests on six convergent evidence streams: (1) cryo-EM structural characterization of the Ascl1-E12a heterodimer on nucleosomes; (2) biochemical demonstration that HASH-1/E2-2 and MASH-1/E47 heterodimers bind CACCTG E-boxes and activate transcription; (3) evolutionary conservation from cnidarians through Drosophila showing achaete-scute homodimers cannot bind DNA; (4) the regulatory logic of Id proteins, which control ASCL1 activity by sequestering E-proteins rather than binding ASCL1 directly; (5) ASCL1 protein stability depending on E-protein availability; and (6) JASPAR motif signatures consistent with class II bHLH:E-protein heterodimer binding patterns. We reviewed 38 papers across three iterations and confirmed 7 findings with verified citations.

The curation recommendation is clear: GO:0042802 should be removed and replaced with GO:0046982 (protein heterodimerization activity) with appropriate experimental evidence codes (IDA/IPI), supported by multiple primary references.

Key Findings

Finding 1: ASCL1 Functionally Binds DNA as an E-Protein Heterodimer

The central finding of this investigation is that ASCL1 requires heterodimerization with class I E-proteins for productive DNA binding and transcriptional activation. UniProt entry P50553 explicitly states that "efficient DNA binding requires dimerization with another bHLH protein" and that ASCL1 "forms a heterodimer with TCF3." This is corroborated by direct experimental evidence from multiple independent laboratories.

Zhou et al. (2026) solved the cryo-EM structure of the Ascl1-E12a heterodimer bound to nucleosomes (PMID: 42285106), demonstrating that "two Ascl1-E12a heterodimers shift and unwrap 15 bp of nucleosomal DNA in a stepwise manner while eliciting solvent exchanges within the octamer." This structural work establishes the heterodimer as the functional unit for pioneer factor activity.

Persson et al. (2000) demonstrated that the HASH-1/E2-2 complex binds a CACCTG E-box in vitro and transactivates an E-box reporter in vivo (PMID: 10903890). They further showed that "E2-2 seems to be one of the major HASH-1 interacting proteins in extracts from neuroblastoma cells," establishing E2-2 (TCF4) as a physiologically relevant partner. Yoshida et al. (2001) demonstrated that MASH-1 binds specifically to a CACCTG E-box "in collaboration with E47, a ubiquitously expressed basic helix-loop-helix (bHLH) factor" (PMID: 11736660).

Critically, while Henke et al. (2009) identified ASCL1 homodimers in vitro, they found these "complexes that in some cases require additional undefined factors for efficient DNA binding" (PMID: 19389376). This observation, rather than contradicting the heterodimer model, reinforces it: homodimers can form under artificial conditions but are not the default functional mode.

Finding 2: GO:0042802 IEA Annotation Lacks Experimental Support

The GO:0042802 (identical protein binding) annotation for ASCL1 is sourced from IEA:Ensembl via GO_REF:0000107 (Ensembl Compara ortholog transfer). This is a purely computational inference with no direct experimental validation. In contrast, the experimentally supported GO annotations paint a consistent picture of heterodimer-mediated function:

The IPI and IDA annotations — the highest-quality experimental evidence — consistently support heterodimer-mediated DNA binding, while the homodimer suggestion comes solely from automated computational inference.

Finding 3: Pioneer Factor Activity Requires the E-Protein Heterodimer

ASCL1's role as a pioneer transcription factor — its ability to access and open closed chromatin — operates through the heterodimer complex. Zhou et al. (2026) demonstrated structurally that "nucleosome association mutants of Ascl1 perturb chromatin opening on linker histone-compacted nucleosome arrays — independent of nucleosome remodelers — and targeting of closed chromatin in vivo, with consequent deficiencies in cellular reprogramming" (PMID: 42285106). This was specifically characterized using the Ascl1-E12a heterodimer complex.

Wapinski et al. (2013) showed that "Ascl1 acts as an 'on-target' pioneer factor by immediately occupying most cognate genomic sites in fibroblasts" (PMID: 24243019). Wang et al. (2023) demonstrated that ASCL1 "opens closed chromatin at the promoters of key ADRN genes" in neuroblastoma (PMID: 38060444). Păun et al. (2023) confirmed that "endogenous expression of ASCL1 drives progenitor differentiation" through pioneer function (PMID: 36931659).

Finding 4: Evolutionary Conservation — Drosophila AS-C Homodimers Cannot Bind DNA

The obligate heterodimer paradigm is deeply conserved across animal evolution. Cabrera & Alonso (1991) provided definitive evidence in Drosophila: "heterodimers of three AS-C products with DA bind DNA strongly, whereas DA homodimers bind weakly and homo or heterocombinations of AS-C products not at all" (PMID: 1915272). This foundational result established that class II bHLH proteins (achaete-scute family) absolutely require class I partners (Daughterless) for DNA binding.

Murre et al. (1989) established the Class A/Class B paradigm, showing that "various HLH proteins can bind as apparent heterodimers to a single DNA motif and also, albeit usually more weakly, as apparent homodimers" (PMID: 2503252). Remarkably, Grens et al. (1995) demonstrated this conservation extends to cnidarians: "In vitro translated CnASH protein can form heterodimers with the Drosophila bHLH protein Daughterless, and these dimers bind to consensus Achaete-scute DNA binding sites in a sequence-specific manner" (PMID: 8575303). This places the achaete-scute/E-protein heterodimer paradigm as conserved across >600 million years of evolution.

Finding 5: Id Protein Regulatory Logic Confirms E-Protein Dependence

The mechanism by which Id proteins regulate ASCL1 provides indirect but compelling evidence for obligate heterodimerization. Jögi et al. (2002) demonstrated that "all four Id proteins could dimerize with E47 or E2-2, but not with HASH-1 or dHAND" (PMID: 11756408). This means Id proteins regulate ASCL1 exclusively by sequestering its E-protein partners — a regulatory mechanism that only makes sense if E-proteins are obligate cofactors for ASCL1 function. If ASCL1 homodimers were functionally sufficient, Id protein sequestration of E-proteins would not effectively inhibit ASCL1 activity.

This finding is further supported by Drosophila evidence. Extramacrochaetae (Emc), the Drosophila Id ortholog, "forms heterodimers with the achaete, scute, lethal of scute and daughterless products" and "inhibits DNA-binding of Achaete, Scute and Lethal of Scute/Daughterless heterodimers and Daughterless homodimers" (PMID: 7821225). The conservation of this regulatory logic across 600+ million years of evolution underscores the fundamental requirement for E-protein heterodimerization.

Finding 6: ASCL1 Protein Stability Depends on E-Protein Availability

Viñals et al. (2004) demonstrated that "Mash1 protein stability is tightly regulated by the E47/Id1 expression ratio" (PMID: 15318167). CK2-mediated phosphorylation of Mash1 at Ser152 "increases interaction of Mash1-E47 heterodimers," further stabilizing the complex. Sriuranpong et al. (2002) showed that "overexpression of the hASH1-dimerizing partner E12 could protect hASH1 from degradation" induced by Notch1 (PMID: 11940670). These findings demonstrate that ASCL1 is not merely functionally dependent on E-proteins for DNA binding but is also physically stabilized by them, suggesting the heterodimer is the default physiological state.

Finding 7: JASPAR Motif Signatures Are Consistent with Heterodimer Binding

JASPAR motif profiles for ASCL1 (MA1100.3, MA1631.2) show binding to CAGCTG/CACCTG E-boxes — canonical class II bHLH:E-protein heterodimer recognition sequences. These motifs are consistent with the established paradigm that class II bHLH proteins bind a slightly different E-box spectrum when complexed with class I partners compared to homodimeric configurations.

Evidence Summary Visualization

Evidence Matrix

Mechanistic Model and Interpretation

Direct Molecular Function

ASCL1 is a class II (Class B) basic helix-loop-helix transcription factor that functions as a functionally obligate heterodimer with class I E-proteins. The mechanistic model can be summarized as follows:

ASCL1 DNA-Binding Mode — Mechanistic Summary
=============================================

  Class II bHLH (tissue-restricted)    Class I bHLH (ubiquitous)
  ┌─────────────┐                      ┌─────────────────────┐
  │   ASCL1      │                      │  E12/E47 (TCF3)     │
  │  (unstable   │──── heterodimer ────>│  E2-2 (TCF4)        │
  │   monomer)   │     formation        │  HEB (TCF12)        │
  └─────────────┘                      └─────────────────────┘
         │                                       │
         │              ┌────────────┐           │
         └──────────────│ ASCL1:E-prot│───────────┘
                        │ heterodimer │
                        └─────┬──────┘
                              │
                    ┌─────────▼─────────┐
                    │  E-box binding     │
                    │  (CAGCTG/CACCTG)   │
                    │  on nucleosomal    │
                    │  DNA               │
                    └─────────┬─────────┘
                              │
                    ┌─────────▼─────────┐
                    │  Pioneer activity: │
                    │  chromatin opening,│
                    │  nucleosome        │
                    │  unwrapping (15bp) │
                    └─────────┬─────────┘
                              │
                    ┌─────────▼─────────┐
                    │  Transcriptional   │
                    │  activation of     │
                    │  neuronal target   │
                    │  genes             │
                    └───────────────────┘

  REGULATION:
  ┌──────┐     sequesters E-proteins
  │  Id  │ ─────────────────────────> Blocks ASCL1 function
  │ 1-4  │     (does NOT bind ASCL1)  (indirect inhibition)
  └──────┘

  ┌──────┐     degrades ASCL1 protein
  │Notch1│ ─────────────────────────> E12 protects from degradation
  └──────┘     (E-protein stabilizes)

  HOMODIMER STATUS:
  • ASCL1:ASCL1 homodimers: form in vitro only
  • Require undefined additional factors for DNA binding
  • Drosophila AS-C homodimers: CANNOT bind DNA at all
  • No in vivo evidence for functional homodimerization

Terminology: "Functionally Obligate Heterodimer"

The term "functionally obligate heterodimer" is the most precise characterization:

• "Functionally" accounts for the minor in vitro homodimer observation (Henke et al. 2009, PMID: 19389376) while correctly stating that productive DNA binding and transcriptional activation require E-protein partners.
• "Obligate" is supported by: (a) no demonstrated homodimer DNA binding for any achaete-scute family member across >600 million years of evolution, (b) E-protein requirement for ASCL1 protein stability, (c) E-protein requirement for pioneer function, and (d) Id protein regulation operating exclusively through E-protein sequestration.

Separating Direct Function from Downstream Consequences

The mechanistic scope of this investigation is limited to the immediate molecular function of ASCL1 — specifically, its dimerization mode and DNA-binding activity. The downstream consequences of ASCL1:E-protein heterodimer function are extensive and include:

• Neurogenesis — ASCL1 drives neural progenitor differentiation (PMID: 36931659)
• Neuroendocrine differentiation — ASCL1 defines SCLC subtypes and cooperates with NKX2-1 (PMID: 31782890)
• Cellular reprogramming — ASCL1 converts fibroblasts to neurons (PMID: 24243019)
• Cancer lineage plasticity — ASCL1 drives neuroendocrine transdifferentiation in prostate cancer (PMID: 40027790)

These are secondary phenotypic outcomes, not the direct molecular function being annotated. The GO curation decision should reflect the proximal biochemical activity: protein heterodimerization leading to sequence-specific E-box binding.

GO Curation Implications

Current Annotations Assessment

Recommended Curation Leads (Require Curator Verification)

1. Remove GO:0042802 (identical protein binding) [IEA:Ensembl]: The electronic annotation suggesting ASCL1 homodimerization is not supported by direct experimental evidence. While Henke et al. 2009 detected homodimers in vitro, these required additional undefined factors and were observed only at specific Dll3 promoter E-boxes. This does not meet the standard for "identical protein binding" as a primary molecular function.

2. Add GO:0046982 (protein heterodimerization activity) with IDA or IPI evidence: ASCL1 heterodimerizes with TCF3/E2A (E12, E47), TCF4/E2-2, and potentially TCF12/HEB. This is well-supported by structural (PMID: 42285106), biochemical (PMIDs: 10903890, 15318167), and genetic (PMID: 22460224) evidence.

3. Retain GO:0070888 (E-box binding) [IDA]: This is the correct DNA-binding annotation. The JASPAR motifs confirm CAGCTG and CACCTG E-box preference.

4. Consider adding a qualifier: The DNA-binding activity of ASCL1 is dependent on E-protein heterodimerization. ASCL1 alone does not efficiently bind DNA.

Conflicts and Alternatives

Evidence for ASCL1 Homodimerization (Conflicting)

The only evidence suggesting ASCL1 homodimer formation comes from Henke et al. (PMID: 19389376), who identified Ascl1/Ascl1 homodimers and Ascl1/Neurog2 heterodimers binding to E-box sites within the Dll3 promoter in vitro. However, these complexes "in some cases require additional undefined factors for efficient DNA binding." This observation does not support functional homodimerization because: (1) it is strictly in vitro; (2) the homodimers are inefficient without unidentified cofactors; (3) no in vivo validation exists; and (4) Drosophila orthologs show zero homodimer DNA-binding capacity.

Potential for Context-Dependent Partners

Several studies suggest ASCL1 may interact with non-E-protein bHLH factors in specific contexts. Henke et al. also observed Ascl1/Neurog2 heterodimers, and the cross-lineage reprogramming study by Dall'Agnese et al. (2022, PMID: 36206732) showed that MEF2C can redirect ASCL1 binding from neuronal to cardiac genes during cross-lineage reprogramming. However, these alternative interactions do not challenge the core finding that E-proteins are the obligate partners for canonical DNA binding.

Paralog and Ortholog Considerations

The GO:0042802 annotation likely derives from ortholog transfer where the source organism's annotation may reflect a different experimental context or a more permissive dimerization assay. Ensembl Compara transfer (GO_REF:0000107) does not discriminate between homodimer-capable and homodimer-obligate bHLH proteins, leading to over-annotation. ASCL1 is the sole member of its achaete-scute family in mammals that is broadly characterized as a pioneer factor. ASCL2, ASCL3, ASCL4, and ASCL5 have distinct expression patterns and likely different dimerization preferences, but they are not typically confused with ASCL1 in annotation pipelines.

Organism-Specific Considerations

Most structural and biochemical evidence uses mouse Ascl1, but human and mouse ASCL1 share >95% identity in the bHLH domain (residues 118–170), making cross-species inference highly reliable. The pioneer factor studies (Wapinski et al. 2013, Păun et al. 2023) span both mouse and human systems with consistent results.

Evidence Base — Key Literature

Structural Evidence

• Zhou et al. (2026) — Distinct associations of pioneer factor Ascl1-E12a with nucleosomes drive changes in cell fate. PMID: 42285106. The definitive structural study showing the Ascl1-E12a heterodimer as the functional pioneer complex. Cryo-EM reveals two heterodimers unwrap nucleosomal DNA. Mutations disrupting nucleosome association impair chromatin opening and cellular reprogramming in vivo.

Biochemical Evidence

• Persson et al. (2000) — HASH-1 and E2-2 are expressed in human neuroblastoma cells and form a functional complex. PMID: 10903890. First demonstration that HASH-1/E2-2 heterodimers bind CACCTG E-boxes and activate transcription in human cells. E2-2 identified as a major HASH-1 interacting protein in neuroblastoma.

• Yoshida et al. (2001) — Proprotein convertase PACE4 is down-regulated by the basic helix-loop-helix transcription factor hASH-1 and MASH-1. PMID: 11736660. Shows MASH-1 binds CACCTG E-box in collaboration with E47.

• Sriuranpong et al. (2002) — Notch signaling induces rapid degradation of achaete-scute homolog 1. PMID: 11940670. E12 protects hASH1 from Notch1-induced ubiquitin-proteasome degradation, demonstrating functional stabilization through heterodimer formation.

• Viñals et al. (2004) — BMP-2 decreases Mash1 stability by increasing Id1 expression. PMID: 15318167. ASCL1/Mash1 protein stability is tightly regulated by the E47/Id1 ratio. CK2 phosphorylation at Ser152 enhances Mash1-E47 heterodimer interaction.

• Sepp et al. (2012) — Pitt-Hopkins syndrome-associated mutations in TCF4 lead to variable impairment of the transcription factor function. PMID: 22460224. TCF4 bHLH domain missense mutations damage DNA-binding in a manner dependent on dimer context (homodimer vs heterodimer with ASCL1), establishing that TCF4-ASCL1 heterodimer is a functional complex.

Evolutionary Evidence

• Cabrera & Alonso (1991) — Transcriptional activation by heterodimers of the achaete-scute and daughterless gene products of Drosophila. PMID: 1915272. The foundational study: AS-C homodimers cannot bind DNA; only AS-C/Daughterless heterodimers bind strongly.

• Murre et al. (1989) — Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. PMID: 2503252. Established the Class A (E12/E47/Da) / Class B (AS-C/MyoD) bHLH paradigm.

• Grens et al. (1995) — Evolutionary conservation of a cell fate specification gene: the Hydra achaete-scute homolog has proneural activity in Drosophila. PMID: 8575303. CnASH/Daughterless heterodimers bind E-boxes — conserved across >600 million years.

Regulatory Evidence

• Jögi et al. (2002) — Modulation of basic helix-loop-helix transcription complex formation by Id proteins during neuronal differentiation. PMID: 11756408. Id proteins bind E47/E2-2 but NOT HASH-1 directly, confirming indirect regulation via E-protein sequestration.

• Cabrera et al. (1994) — Regulation of scute function by extramacrochaete in vitro and in vivo. PMID: 7821225. Emc (Drosophila Id ortholog) inhibits DNA-binding of AS-C/Da heterodimers, confirming conservation of E-protein-dependent regulation.

Qualifying Evidence

• Henke et al. (2009) — Ascl1 and Neurog2 form novel complexes and regulate Delta-like3 (Dll3) expression in the neural tube. PMID: 19389376. Reports in vitro Ascl1 homodimers, but these require additional undefined factors. Does not demonstrate in vivo homodimer function.

Knowledge Gaps

Discriminating Tests

The following experiments would most efficiently distinguish the heterodimer-obligate model from alternatives:

1. E-protein conditional knockout + ASCL1 ChIP-seq: Deplete all class I E-proteins (TCF3, TCF4, TCF12) via conditional knockout or triple siRNA, then perform ASCL1 ChIP-seq. If ASCL1 chromatin binding is abolished genome-wide, this proves obligate heterodimerization. If a subset of sites retains binding, those are candidate homodimer-dependent sites.

2. ASCL1 dimerization-deficient mutants: Engineer ASCL1 mutations in the HLH domain that selectively abolish homodimerization while preserving heterodimerization (or vice versa). Test each mutant for DNA binding, transcriptional activation, and pioneer activity.

3. In vivo proximity labeling (BioID/TurboID): Express ASCL1-TurboID in neural progenitor cells and identify proximal proteins during DNA binding. This would reveal whether ASCL1 predominantly engages E-proteins or self-associates on chromatin.

4. AlphaFold-Multimer prediction: Model ASCL1:ASCL1 homodimer vs. ASCL1:E12 and ASCL1:E47 heterodimers to compare predicted binding energies and interface quality scores.

5. Single-molecule FRET: Label ASCL1 and E-proteins with different fluorophores and measure real-time dimerization dynamics on E-box DNA to determine relative affinities.

Curation Leads

All leads below require curator verification.

Lead 1: Remove GO:0042802 (Identical Protein Binding)

• Current: GO:0042802 [IEA:Ensembl] via GO_REF:0000107 (Ensembl Compara ortholog transfer)
• Recommendation: Remove. No direct experimental evidence supports ASCL1 homodimerization as a functional binding mode.
• Provenance confirmed: QuickGO shows this annotation derives from automated ortholog transfer, not from domain prediction or experimental evidence.
• Key contradicting evidence: Drosophila AS-C homodimers cannot bind DNA at all (PMID: 1915272); structural characterization uses heterodimer complex (PMID: 42285106).
• Candidate snippet to verify: From PMID: 1915272: "heterodimers of three AS-C products with DA bind DNA strongly, whereas DA homodimers bind weakly and homo or heterocombinations of AS-C products not at all"

Lead 2: Add GO:0046982 (Protein Heterodimerization Activity)

• Recommendation: Add GO:0046982 with IDA or IPI evidence code.
• Supporting references: PMIDs: 42285106, 10903890, 11736660, 11940670, 15318167, 22460224.
• Candidate snippet to verify: From PMID: 10903890: "E2-2 interacts with HASH-1 in both yeast and mammalian cells. The HASH-1/E2-2 complex binds an E-box (CACCTG) in vitro, and transactivates an E-box containing reporter construct in vivo"

Lead 3: Retain GO:0070888 (E-Box Binding) and GO:0043425 (bHLH TF Binding)

• Status: Already well-supported by IDA and IPI experimental evidence.
• Rationale: These annotations are directly validated and consistent with the heterodimer model.

Lead 4: Consider Adding Explicit E-Protein Partners as Interactors

• Candidate interactors: TCF3 (E2A/E12/E47), TCF4 (E2-2), TCF12 (HEB)
• Evidence: PMIDs: 10903890, 11736660, 42285106, 11940670, 15318167, 22460224

Lead 5: Consider GO:0071837 (HLH Domain Binding) as Alternative

• If the curation standard requires acknowledging ASCL1's dimerization capacity without specifying homo- vs. heterodimer, GO:0071837 or a parent term may be more appropriate than GO:0042802.

Limitations

1. In vitro vs. in vivo: Most dimerization evidence comes from in vitro assays (EMSA, co-IP). While the cryo-EM work (PMID: 42285106) includes in vivo validation, a systematic in vivo demonstration of obligate heterodimerization (e.g., through E-protein knockout) has not been performed.

2. Tissue specificity: Different E-protein partners may dominate in different tissues (E2-2 in neuroblastoma, E47 in neural tube, E12a in reprogramming). The functional implications of partner choice are not fully resolved.

3. "Obligate" qualifier: The term "functionally obligate" is used cautiously. ASCL1 homodimers can form in vitro (PMID: 19389376), so ASCL1 is not structurally incapable of homodimerization. Rather, homodimers appear to be non-functional or extremely inefficient without additional (unidentified) cofactors.

4. Evolutionary inference: The Drosophila evidence (PMID: 1915272) is the strongest argument against homodimer function, but cross-species extrapolation carries inherent uncertainty, particularly given 600+ million years of divergence.

5. Incomplete GO provenance: The exact source ortholog and evidence chain for the Ensembl Compara transfer (GO_REF:0000107) could not be fully traced. It is possible the source annotation reflects a valid observation in another species.

Proposed Follow-up Actions

1. Curator action (immediate): Review and remove GO:0042802; add GO:0046982 with appropriate experimental evidence codes (IDA/IPI) referencing PMIDs: 42285106, 10903890, 11940670.

2. Database query: Trace the specific Ensembl Compara ortholog pair and source evidence for GO:0042802 to determine if this is a systematic issue affecting other class II bHLH proteins (ASCL2, ATOH1, NEUROD1, NEUROG1/2).

3. Literature survey extension: Search for any in vivo evidence of ASCL1 homodimer function in disease contexts (particularly SCLC and neuroblastoma, where ASCL1 is highly expressed and E-protein levels may be limiting).

4. Experimental proposal: ASCL1 ChIP-seq in E-protein triple-knockout cells (TCF3/TCF4/TCF12) to definitively test whether any ASCL1 chromatin binding persists without E-protein partners. This would provide the definitive "gold standard" evidence for obligate heterodimerization.

5. Systematic annotation review: Check whether other class II bHLH transcription factors (NEUROD1, NEUROG2, ATOH1, MYOD1) carry similar GO:0042802 IEA annotations that may also be over-annotated relative to their E-protein dependence.